PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2020-12-23

Date Title Company
23-Dec-2020 Radiation-Induced Myelosuppression Treatment Market Exploring Future Growth 2020-2030| Opportunities & Development MARKITWIRED
23-Dec-2020 Onychomycosis Treatment Market Analysis, Growth by Top Companies, Trends by Application, Forecast – 2030 MARKITWIRED
23-Dec-2020 Therapeutic Nuclear Medicines Market SWOT analysis and Key Business Strategies, Demand & Forecast – 2030 MARKITWIRED
23-Dec-2020 Global Protein Expression Market to Register Exponential Growth During COVID-19 Pandemic MARKITWIRED
23-Dec-2020 North America to bank on Extensive research in the Ophthalmology Devices market from 2020 to 2030 MARKITWIRED
23-Dec-2020 Xlife Sciences AG: Exit of a project company Xlife Sciences AG
23-Dec-2020 North America to witness a Substantiated Growth in the Intraocular Lens market from 2020 to 2030 MARKITWIRED
23-Dec-2020 North America to Walk the “Innovation-Centric” Talk in the Intravenous Iron Drugs market between 2020 and 2030 MARKITWIRED
23-Dec-2020 Europe to be Led by techno-Commercial Innovations in Molecular Diagnostics Market from 2020 to 2030 MARKITWIRED
23-Dec-2020 North America to Outshine the Global Slowdown in Mobility Aids Transportation Equipment Market between 2020 and 2030 MARKITWIRED
23-Dec-2020 Veterinary Ultrasound Scanners Market in Good Shape in 2020; COVID-19 to Affect Future Growth Trajectory MARKITWIRED
23-Dec-2020 Niacin and Niacinamide Market Recorded Strong Growth in 2020; COVID-19 Pandemic Set to Drop Sales MARKITWIRED
23-Dec-2020 Swine Respiratory Diseases Treatment Market in Good Shape in 2020; COVID-19 to Affect Future Growth Trajectory MARKITWIRED
23-Dec-2020 The Global Medical Device Cleaning Market is emerging market demand in the wake of increasing hospital-acquired infection and the growing geriatric population Shingetsu research
23-Dec-2020 BioInvent receives $3 million payment related to selection of antibodies under collaboration with Pfizer Inc. BioInvent
23-Dec-2020 Innovent Announces NMPA Granted New Indication Approvals for SULINNO® (Adalimumab Injection) for the Treatment of Pediatric Plaque Psoriasis and Non-infectious Uveitis Innovent Biologics
23-Dec-2020 Innovent Announces NMPA Granted New Indication Approvals for SULINNO® (Adalimumab Injection) for the Treatment of Pediatric Plaque Psoriasis and Non-infectious Uveitis Innovent Biologics